Our consultants

Dr Wale Atoyebi is Consultant Haematologist at Oxford University Hospitals and Honorary Senior Clinical Lecturer at University of Oxford.

His basic and specialist haematology training was in Oxford. His main interest is in red cell disorders.

He sits on the NHS England Clinical Reference Group for Haemoglobinopathies and is co-author of UK Standards of Care for adults with Sickle Cell Disease.

He is also involved in collaborative research focused on strengthening healthcare systems by improving best practice in the diagnostics and management of sickle cell disease in Sub-Saharan Africa.

Dr Sylvia Benjamin is Consultant Haematologist, NHS Blood and Transplant (NHSBT) and OUH. She trained at University College Hospital London (1983), Fred Hutchinson Cancer Centre Seattle and Royal Marsden London before completing training at Oxford.

She is Lead for Thames Valley NHSBT Therapeutic Apheresis Services, supporting the OUH Haematology Department's cancer, stem cell transplant and sickle services, and other departments such as Neurology and Obstetrics. She has a special interest in TTP, researching with UK TTP Registry, and is co-author of BSH Guideline.

Her other interests include educational supervision, coaching, mentoring and appraisal. She tweets #blooducation #SBCandM @Gogmum

Dr Chowdhury studied undergraduate medicine in Cambridge before completing her clinical training in Oxford. Her specialist haematology training was undertaken at University College, London and Oxford University Hospitals.

She joined the Weatherall Institute for Molecular Medicine in 2010, undertaking a Wellcome Trust DPhil Fellowship, characterising and targeting the stem cells which drive myelodysplastic syndromes. She has been awarded an MRC Clinical Academic Partnership to improve the diagnosis of myeloid diseases.

She looks after patients with myeloid diseases and is clinical lead for the Flow Cytometry Service.

Dr Collins trained in medicine at Cambridge and St Bartholomew's and the Royal London Hospitals. His specialist haematology training was in Oxford.

Dr Collins sits on the high grade and Hodgkin lymphoma national study groups and is also a member of the lymphoma guidelines development group of NICE. He co-authored the national guidelines for relapsed Hodgkin Lymphoma. He is also a trustee of the national Lymphoma Association.

Dr Nicola Curry is a Consultant Haematologist at the Oxford Haemophilia and Thrombosis Centre and she looks after adults with inherited and acquired bleeding and thrombotic disorders.

Her main research interests are in the treatment of acquired coagulopathy, in particular traumatic coagulopathy and the role of early fibrinogen replacement during active major haemorrhage.

Dr Curry is a Principal Investigator and Chief Investigator for various research studies at Oxford University Hospitals, including studies for acquired and inherited bleeding and thrombotic disorders.

Dr Hay qualified in medicine at Oxford, and undertook her postgraduate training in Oxford, London and Glasgow.

She now works mainly for Oxford's Clinical Medical School, where she is responsible for education in pathology and laboratory medicine disciplines.

As an honorary consultant haematologist, she focuses on the care of patients with haemoglobin disorders and on laboratory diagnostics.

Dr Kothari completed undergraduate studies at the University of Cambridge, before attending medical school at Brasenose College, Oxford.

After qualification he trained in clinical haematology at University College Hospital ,London, focusing on the comprehensive management of lymphoid malignancies.

He also spent two years working on the early-phase development of monoclonal antibodies for Non-Hodgkin lymphomas. As a consultant in Oxford he works across the lymphoma and plasma cell dyscrasia services and is clinical lead for the late phase clinical trial group.

Dr Mead trained in medicine at Oxford, and trained in haematology at St Bartholomew's Hospital and University College London.

His 2007 PhD focused on the biology of myeloid leukaemias. His specialist interest is clinical and basic research into myeloid disorders, and he runs a research group at the Weatherall Institute of Molecular Medicine (WIMM) focused on myeloid diseases and normal blood stem cell biology

Mike Murphy is Professor of Transfusion Medicine at the University of Oxford and is Consultant Haematologist for NHS Blood and Transplant (NHSBT) and Oxford University Hospitals. He studied medicine and completed his haematology training at St Bartholomew's Hospital, and became a Senior Lecturer in Haematology there in 1985. In 1996, he moved to Oxford and in 2004 became Professor of Blood Transfusion Medicine.

The work done by he and his colleagues using technology to improve the safety and effectiveness of transfusion practice has won numerous national awards and is an exemplar for the NHS QIPP initiative. He co-founded the NHSBT Clinical Studies Unit, its Systematic Reviews Initiative and the Transfusion Evidence Library.

Please also see the Radcliffe Department of Medicine website.

Prof Michael Murphy: Publications March 2016 (pdf, 212 KB)

Dr Pawson is Consultant in Haematology and Transfusion Medicine, NHS Blood and Transplant, and Honorary Consultant, Honorary Senior Clinical Lecturer, University of Oxford.

She has been part of OUH since October 2001, and is a consultant in the NHSBT Oxford Stem Cell and Immunotherapy (SCI) Laboratory and Therapeutic Apheresis Service, managing patients undergoing stem cell and lymphocyte collections, extracorporeal photopheresis and other apheresis procedures.

She is also Acting Medical Director of the British Bone Marrow Registry and NHS Cord Blood Bank, and part of the OUH Blood and Marrow Transplant team, seeing patients in the post-transplant outpatient clinic and undertaking counselling and medical assessment of family donors.

Dr Pavord is Consultant Haematologist at Oxford University Hospitals and Associate Senior Lecturer in Medicine. Her special areas of interest are obstetric haematology, haemostasis, thrombosis and transfusion medicine.

She is co-chair of the BSH Obstetric Haematology Group and joint editor of the Obstetric Haematology Manual (Pavord Hunt). She runs an international course on haematology in obstetrics and has authored national guidelines in the field.

Dr Peniket trained in medicine in Oxford and Cambridge before working in bone marrow transplantation in London. As a consultant in Oxford he has worked with leukaemia, myeloma and transplant patients.

He is Clinical Director of Haematology and Bone Marrow Transplantation in Oxford and Chair of the British Society of Bone Marrow Transplantation Clinical Trials Committee. He is also a member of the national Clinical Reference Groups both for bone marrow transplantation and chemotherapy.

Dr Ramasamy completed Internal Medicine training in Nottingham and started his career in haematology at Glasgow. He completed a comprehensive haematology registrar training programme at King's College London, researching both clinical and laboratory aspects of myeloma.

He is Lead Clinician for myeloma and other plasma dyscrasias in Thames Valley Strategic Clinical Network and Divisional Lead of Cancer Research across Thames Valley and South Midlands Research Network.

Dr Noémi Roy trained in medicine in Edinburgh and carried out her haematology training in London and Oxford. Her main interests are haemoglobinopathies and rare inherited anaemias, and in particular the genetic investigation of inherited anaemias, including whole genome sequencing.

She is also involved in investigating the management of iron deficiency in diverse patient groups. She is dedicated to using patients' views to guide how research in conducted in haematology and coordinating best practice care in red cell disorders at the European level.

Professor Anna Schuh is Director of Molecular Diagnostics at the University of Oxford and an Honorary Consultant Haematologist.

She has participated as a principal or chief investigator in over 30 early or late phase clinical trials in chronic lymphocytic leukaemia. A number of these led to subsequent NICE approvals and have changed clinical practice in the UK and worldwide.

Her primary research interest is with the development, evaluation and implementation of new technologies for precision diagnostics with a particular focus on genomics.

Dr Shapiro qualified from the University of Oxford Medical School and trained further in haematology at the Hammersmith, Royal Free and Great Ormond Street Hospitals in London. Her PhD at Imperial College London focused on the structure and function of von Willebrand factor.

She worked as a Consultant for a year at Guys and St Thomas' Hospital London before joining the Oxford Haemophilia and Thrombosis Centre in 2015. She works entirely in the field of haemostasis and thrombosis: haemophilia and other bleeding disorders, thrombosis and anticoagulation.

Prof Simon Stanworth's professional profile can be found here.

Prof Vyas is Professor of Haematology and Consultant Haematologist in myeloid disorders. He studied medicine at Cambridge and Oxford, and, after general medical training in London, he completed a PhD on the control of gene regulation with Prof Doug Higgs and Prof Sir David Weatherall at the MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine (WIMM).

His long-term interest is understanding the molecular basis of haematological disease, and he runs a research laboratory in the MRC Molecular Haematology Unit.